Effects of laser on preventing decreased sensitivity in women with breast cancer during chemotherapy
- Conditions
- Tactile PerceptionF02.463.593.894
- Registration Number
- RBR-9wsg72
- Lead Sponsor
- niversidade Federal de Minas Gerais
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Pathologic anatomic report of cancer;
Beginning of treatment with antineoplastic chemotherapy containing taxanes, platines, vinca alkaloids and bortezomib alone or in combination;
Absence of PSTA, identified by symptom reporting and stoichiometry test;
Adults above 18 years.
Hoseniasis;
Diabetes melittus;
Cognitive deficits;
Other neuropathies, including those caused by tumor infiltration;
Absence of verbalization;
Pregnant;
Performance Status greater than or equal to 3;
Acupuncture in the last 6 months for neuropathy;
Alcoholism;
Skin problems in the irradiated area;
Presence of the tumor at the irradiation sites.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method It is expected that the difference between the groups for tactile sensory perception is up to 30% by the stoichiometry and questionnaire of neuropathy induced by chemotherapy<br><br>
- Secondary Outcome Measures
Name Time Method Differences between groups for neuropathic pain are expected to be up to 5% for the neuropathic pain questionnaire Douleur neuropathique 4 questions;It is expected that the difference between the groups for anxiety is up to 60% for the Anxiety and Depression Scale (HADS);The difference between the groups for depression is expected to improve by up to 30% for the anxiety and depression questionnaire (Hospital Anxiety and Depression Scale - HADS);The difference between the groups for quality of life is expected to be up to 70% by the Functional Assessment of Cancer Therapy / Neurotoxicity (FACT / GOG-NTx)